Families struggle to find affordable, reliable home health aides; reports of increased pediatric pneumonia cases; legal battle ensues over Purdue Pharma’s bankruptcy settlement.
Millions of American families face challenges in securing trustworthy home health aides, according to Kaiser Health News. As a shortage of workers exacerbates the issue, families must navigate a maze of agencies, often resorting to untrained caregivers found through word of mouth. With the high cost of care and limited government assistance available, families face financial strain and are in desperate need of support when navigating the complex landscape of home care services.
Several countries, including China, Denmark, France, the Netherlands, and specific regions in the United States, have witnessed a surge in pediatric pneumonia cases associated with Mycoplasma pneumoniae, prompting concerns globally, according to CNN. While this bacterium causes periodic outbreaks, experts suggest that the ongoing increase might be more pronounced this year, with Europe and Asia experiencing a 4-fold rise in reported cases. The rise is attributed to factors such as antibiotic resistance.
The US Supreme Court is poised to deliberate on the legality of Purdue Pharma's approximately $6 billion bankruptcy settlement, a move that could impact the resources available to those affected by the opioid crisis, according to Reuters. If approved, the settlement would transform Purdue into a nonprofit entity, allocate funds to address opioid addiction harms, and shield the wealthy Sackler family, Purdue's owners, from lawsuits related to the opioid epidemic.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More